PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsMedicure
Medicure(MCU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AggrastatTirofiban1998-05-14
Myocardial infarction
,
Coronary disease
,
Unstable angina
ZypitamagPitavastatin2017-07-142024-2031
Hypercholesterolemia
,
Hypertriglyceridemia
,
Hyperlipoproteinemias
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Tirofiban
renal insufficiency
,
hemorrhage
,
covid-19
,
coronavirus infections
,
respiratory insufficiency
,
embolism and thrombosis
,
pneumonia
,
viral pneumonia
,
stable angina
,
death
,
subarachnoid hemorrhage
,
syndrome
,
unstable angina
,
thromboembolism
,
ischemic stroke
,
myocardial infarction
,
st elevation myocardial infarction
,
infarction
,
coronary artery disease
,
acute coronary syndrome
,
stroke
,
inferior wall myocardial infarction
,
percutaneous coronary intervention
,
cerebral infarction
,
thrombosis
,
no-reflow phenomenon
,
non-st elevated myocardial infarction
,
coronary disease
,
intracranial aneurysm
,
ischemia
,
aneurysm
,
balloon angioplasty coronary
,
diabetes mellitus
,
thrombolytic therapy
,
thrombectomy
,
myocardial ischemia
,
magnetic resonance imaging
,
disease
,
pathologic dilatation
,
pathologic constriction
Bevifimod
pancreatic neoplasms
,
type 2 diabetes mellitus
,
recurrence
,
renal cell carcinoma
,
carcinoma
,
colorectal neoplasms
,
neoplasms
,
mantle-cell lymphoma
,
rectal neoplasms
,
adenocarcinoma
,
chronic hepatitis c
,
lung neoplasms
,
brain neoplasms
,
squamous cell carcinoma of head and neck
,
cytokine release syndrome
,
neurotoxicity syndromes
,
syndrome
,
large b-cell lymphoma diffuse
,
colonic neoplasms
,
kidney diseases
,
membranous glomerulonephritis
,
chronic hepatitis b
,
mycoses
,
hematopoietic stem cell transplantation
,
male breast neoplasms
,
skin neoplasms
,
mouth neoplasms
,
oropharyngeal neoplasms
,
laryngeal neoplasms
,
hypopharyngeal neoplasms
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
non-hodgkin lymphoma
,
non-small-cell lung carcinoma
,
b-cell lymphoma
,
breast neoplasms
,
acquired immunodeficiency syndrome
,
follicular lymphoma
,
hepatitis c
,
triple negative breast neoplasms
,
hiv
,
leukemia
,
lymphoid leukemia
,
b-cell lymphoma marginal zone
,
waldenstrom macroglobulinemia
,
cystic fibrosis
,
pseudomonas infections
,
rheumatoid arthritis
,
infections
,
hepatitis b
,
communicable diseases
,
hepatitis
,
hepatitis a
,
psoriatic arthritis
,
covid-19
,
coronavirus infections
,
severe acute respiratory syndrome
,
virus diseases
,
coronaviridae infections
,
nidovirales infections
,
rna virus infections
,
stomach neoplasms
,
hiv infections
,
b-cell leukemia
Retinol
sezary syndrome
,
mycosis fungoides
,
t-cell lymphoma cutaneous
,
primary cutaneous anaplastic large cell lymphoma
,
recurrence
,
t-cell lymphoma peripheral
,
neoplasm metastasis
,
lymphoma
,
t-cell lymphoma
,
breast neoplasms
,
carcinoma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
leukemia
,
non-hodgkin lymphoma
,
extranodal nk-t-cell lymphoma
,
hodgkin disease
,
waldenstrom macroglobulinemia
,
b-cell lymphoma
,
large-cell lymphoma anaplastic
,
immunoblastic lymphadenopathy
Pyridoxal
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use